ramos2
@ramos262740691 · X
リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 130 likes · 66 shares · 17,160 followers
View post →
N Engl J Med April 2020 PMID 32109013
Clinical Characteristics of Coronavirus Disease 2019 in China.
Mentions
1,107
Peak: 134 in Mar 2020
across 7 sources since Mar 2020
Extended reach
8,532,920
potential audience
Total likes
6,691
Video views
263,712
Mentions per month
Mar 2020 – Sep 2025Where it's discussed
-
News570 articles
-
X / Twitter349 posts
-
Blogs82 articles
-
Facebook62 posts
-
YouTube28 videos
-
Reddit12 posts
-
Bluesky4 posts
AI synopsis
What people are saying
The discussions surrounding the referenced video highlight the critical nature of understanding COVID-19 through the lens of scientific evidence, particularly relating to symptoms, patient characteristics, and public health implications. For instance, tweets express the importance of recognizing key symptoms like fever and cough, and emphasize the need to understand who is at higher risk as illustrated in the publication and its exploration of ICU admission and death rates. Many tweets employ an informative and reassuring tone, citing the urgency of sharing accurate information for public health, as seen in phrases like 'evidencia científica' and calls to action like '¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER!', underscoring the necessity for community awareness during the pandemic.
AgreementNeither agree nor disagree
InterestNeutral interest
EngagementNeutral engagement
ImpactNeutral impact
Abstract in brief
- Covid-19 originated in Wuhan in December 2019 and rapidly spread across China, requiring data on patient characteristics.
- A study analyzed 1,099 confirmed Covid-19 patients from 30 regions in China, focusing on critical outcomes like ICU admission and death, finding an overall composite end point rate of 6.1%.
- Key symptoms included fever (88.7% during hospitalization) and cough (67.8%), with a median incubation period of 4 days, while many patients displayed no significant radiologic abnormalities despite severe disease presentations.
Top posts
Most liked on X and BlueskyChubbyemu
@chubbyemu · X
I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 78 likes · 10 shares · 104,574 followers
View post →
Kang Santabrata
@KangSantabrata · X
INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb kasus berarti 58rb perlu dirawat (58%), 5rb perlu ICU (5%) dan 3400 diperkirakan meninggal (3,4% CFR WHO). Siap? Ref: https://t.co/cc7X4jmEoX #Covid19 https://t.co/fgoNZz37Lb
Mar 23, 2020 · 33 likes · 38 shares · 988 followers
View post →
Alfons López Tena
@alfonslopeztena · X
Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients, thrombocytopenia in 36.2%, and leukopenia in 33.7%. Most of the patients had elevated levels of C-reactive protein https://t.co/xHoS7YZPi5
Apr 15, 2020 · 30 likes · 24 shares · 188,453 followers
View post →
mitsaki - protect the
@micaki · X
@RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore the data and pretend all will fine. China, April 2020: "Lymphocytopenia was present in 83.2% of the patients on admission." https://t.co/PGCMS2ezPO
Oct 23, 2022 · 30 likes · 4 shares · 133 followers
View post →
Masato Ida, PhD
@miakiza20100906 · X
論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMafzw 2020年、Guan（広州医科大学／中国）ら。中国の552病院、計1099人の患者の特徴について。
May 6, 2020 · 18 likes · 12 shares · 8,050 followers
View post →
All mentions
Analysis of COVID-19 Patient Characteristics in China
This episode presents a detailed analysis of 1,099 confirmed COVID-19 patients in China. Key findings include high rates of fever (88.7%) and cough (67.8%), with a notable median incubation period of 4 days.
Heme Review · Mar 15, 2020
235,901 views
Traitements du COVID-19 : hydroxychloroquine, remdesivir, lopinavir... ANALYSE des essais cliniques
Thibault Fiolet · Mar 29, 2020
11,018 views
Signs and Symptoms of COVID-19: Key Findings and Risks
Doctor Bobby · Mar 27, 2020
4,194 views
Scientific Analysis of COVID-19 Documentary and Virus Information
Reaccionando al documental AISLADOS de JUANPA ZURITA y LUISITO COMUNICA con evidencia científica. Conoce mi opinión basada en artículos de revistas de alto impacto sobre el coronavirus SARS CoV 2.
Doctor Bobby · Jun 10, 2020
3,722 views
COVID-19 Digest: Could Cigarette Smoking Actually be Protective Against COVID?
Emergency Medical Minute · May 13, 2020
1,484 views
COVID-19 Pathophysiology and Patient Characteristics Overview
Welcome to an update on SARS-CoV-2 infection, including key clinical features and outcomes. This video presents data from a study analyzing 1,099 confirmed COVID-19 cases, highlighting symptoms like fever and cough, and…
Samal Nauhria · Mar 31, 2020
1,329 views
Impact of Covid-19 on Immunosuppressed Patients Explained
Since GEASSEMI, we emphasize reassurance for our immunosuppressed patients. It’s crucial not to abandon immunosuppressive treatments without consulting a doctor. Current data shows that while limited, patients on…
GEAS SEMI · Mar 3, 2020
1,206 views
Coronavirus in Tears and Eye Secretions: Implications for Transmission
This video discusses the presence of coronavirus in tears and conjunctival secretions of SARS-CoV-2 infected patients and explores implications for transmission and eye health.
Biotech Academy · Mar 21, 2020
1,116 views
Coronavirus Transmission through Eye Contact and Conjunctivitis Risks
Dr Rupal discusses recent case studies indicating coronavirus can spread via eye contact and conjunctivitis. The video covers how direct contact with mucosal membranes may facilitate transmission and highlights…
ThinkPill · Mar 30, 2020
957 views
Understanding COVID-19 Epidemiology and Severity Based on Current Evidence
Since December 2019, new pneumonia cases in Wuhan led to the discovery of the novel coronavirus. This video provides an overview of COVID-19's epidemiology and severity, highlighting key research efforts for better…
Smart Med · Mar 29, 2020
512 views
Therapeutic Controversies During COVID-19 Pandemic Analysis
ACEIs, ARBs, NSAIDs, acetaminophen, and steroids in COVID-19 treatment are analyzed, focusing on their effects on the cardiovascular system and symptom management, with insights from recent clinical studies and…
Alvaro Puig MD · Apr 10, 2020
344 views
Key Findings on COVID-19 Patient Characteristics in China
This video covers critical insights from a study analyzing 1,099 confirmed COVID-19 patients in China. Key symptoms included high rates of fever and cough, with an overall composite endpoint rate of 6.1% for ICU…
Dr. Teoto · Mar 18, 2020
275 views
Exploring the Wonders of Quantum Mechanics and Its Applications
This video explores the fascinating world of quantum mechanics, detailing its fundamental principles and real-world applications. Delve into how quantum phenomena influence modern technology, from quantum computing to…
TerraKOT Tech · Mar 26, 2020
261 views
Necessity of Social Isolation in Brazil During COVID-19 Pandemic
This video discusses the controversy surrounding social isolation versus returning to work in Brazil, using data to evaluate the need for social distancing measures during the COVID-19 pandemic. It aims to inform public…
Smart Med · Mar 30, 2020
228 views
Understanding Burnout and COVID-19 Related Myocarditis Risks
This video discusses burnout syndrome and evaluates susceptibility among professions. It reflects on COVID-19 data, including symptoms like fever and how this pandemic influenced patient experiences. Join for insights…
Scienarq · Jan 8, 2023
156 views
Ethics of Resource Allocation in COVID-19 Healthcare Decisions
COVID-19 has tested the limits of our National Health Service like never before, prompting a reassessment of ethical guidelines for healthcare resource distribution. This video explores the conflict between ethical…
Methix Cambridge · Jan 24, 2021
155 views
Economic Impact of COVID-19 and Policy Responses
Analyzing the current economic situation and the implications of strict quarantine measures based on scientific and historical insights. This video explores whether early return to normalcy is advisable, supported by…
Smart Med · Apr 1, 2020
137 views
COVID-19 Insights and Prevention with Dr. Mario Pérez
In this video, Dr. Mario Alfredo Pérez De La Torre discusses the current COVID-19 situation, offering valuable insights and prevention recommendations. The information, while focused on Mexico, is applicable globally…
M.K. Mousanz · Mar 22, 2020
114 views
SARS-CoV-2: Key Insights on COVID-19 Characteristics and Outcomes
This video answers 24 frequently asked questions about SARS-CoV-2. It includes vital information about symptom prevalence such as fever and cough, as well as critical outcomes like ICU admissions from a study of 1,099…
Truthdoc · Oct 2, 2020
102 views
Understanding COVID-19: Transmission and Complications
Neste vídeo, iremos falar sobre COVID-19, suas origens e modos de transmissão. Estudaremos ainda as complicações de coagulação, onde altos índices de trombose e sangramento foram observados. Aprofunde-se nos tratamentos…
Neuro Sapiens em Minutos · Nov 18, 2021
92 views
Understanding COVID-19 Tests and Symptoms
This video explains COVID-19 transmission, symptoms, and how testing works, based on research from the University of Brasilia. It aims to provide a clear understanding of how COVID-19 is detected and its health impacts.
Neuro Sapiens em Minutos · Nov 25, 2021
84 views
Expert Advice on COVID-19 Prevention and Management in Mexico
Dr. Mario Alfredo Perez De La Torre shares valuable insights on COVID-19, focusing on preventive measures, especially for those with chronic illnesses. His guidance is applicable globally, emphasizing the importance of…
M.K. Mousanz · Mar 23, 2020
83 views
Can I Catch COVID-19 Again? Expert Advice on Reinfection Risks
Dr. Mario Alfredo Perez De La Torre discusses COVID-19 reinfection risks and provides effective prevention tips, emphasizing the importance for individuals with chronic illnesses to stay vigilant during the pandemic.
M.K. Mousanz · Mar 23, 2020
80 views
COVID-19 Enemy Analysis and Protective Measures Effectiveness
COVID19 Lets meet our enemy fully armed. This video discusses the seriousness of the situation, the cunning of the virus, and the importance of measures such as masks and PPE. It emphasizes the need for clear guidelines…
TerraKOT Tech · Apr 12, 2020
71 views
COVID-19 Impact and Prevention Strategies in Mexico
This video discusses the current COVID-19 situation in Mexico, offering valuable prevention tips and insights from Dr. Mario Alfredo Perez De La Torre, focusing on protecting vulnerable populations and understanding the…
M.K. Mousanz · Mar 23, 2020
44 views
Understanding COVID-19 and Prevention Strategies from an Expert
M.K. Mousanz · Mar 23, 2020
26 views
COVID-19 Rumor Debunking and Prevention Strategies Explained
Due to the current global situation, this video provides accurate information about COVID-19, focusing on prevention and health recommendations, especially for those with chronic illnesses. Shared by Dr. Mario Alfredo…
M.K. Mousanz · Mar 23, 2020
17 views
Effective Cleaning Measures to Prevent COVID-19 Transmission
This video provides valuable recommendations for preventing COVID-19 infection, emphasizing the importance of hygiene practices and precautions especially for those with chronic illnesses. It aims to help viewers…
M.K. Mousanz · Mar 23, 2020
12 views
GGrok
@grok · X
@Charger55555 @DrBenTapper1 The term "COVID-19" was first used by WHO on February 11, 2020, in their official naming announcement. An early scientific paper using it is "Clinical Characteristics of Coronavirus Disease 2019 in China," published in NEJM on February 28, 2020. Patents mentioning "COVID-19"
Sep 21, 2025 · 6,692,051 followers
View post →
たまサポ(玉造順一さん勝手連)
@tamachankensei · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 14, 2025 · 66 shares · 1,021 followers
View post →
HAYASHI, Yoshi-Yuki
@atm09rs · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 14, 2025 · 66 shares · 145 followers
View post →
豆ち System-R
@CunZhi56150 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 13, 2025 · 66 shares · 9,960 followers
View post →
ROMANI 9月23日に新PCが届く人
@hakooshi2019 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 13, 2025 · 66 shares · 1,581 followers
View post →
ポン吉仙人258
@CgqoaLk · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 13, 2025 · 66 shares · 1,075 followers
View post →
ぷちぐら
@80r6YUQeR7aF4ES · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Sep 12, 2025 · 66 shares · 204 followers
View post →
meltypot
@meltypot · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Aug 31, 2025 · 66 shares · 1,143 followers
View post →
長谷川淳史
@TMS_Japan · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 21, 2025 · 66 shares · 4,951 followers
View post →
赤
@aka_salticidae · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 21, 2025 · 66 shares · 1,549 followers
View post →
Art Lab
@daemonzhang6 · X
@LauraMiers "Lymphocytopenia was present in 83.2% of the patients on admission." [January 29, 2020; Wuhan] Clinical Characteristics of Coronavirus Disease 2019 in China - PMC
May 18, 2025 · 5 likes · 1 share · 1,372 followers
View post →
Giuseppe Vetrugno
@GiuseppeVetrug1 · X
@ayrvian @semeraro_g @Lidia_Undiemi Mancava questo. https://t.co/3GSvS2T04g
Mar 18, 2025 · 1 like · 761 followers
View post →
James Lynch
@JamesLynchGTC · X
@paramaniac9 @DrMohammadIAdi1 1. "No fever"??? 2. That's a very limited description of the symptoms. Try this: https://t.co/WOrGabouIo 3. And then explain the laboratory and radiographical characteristics in the same paper. 4. And again...if they walked them to a ventilator...how do you get 50% mortality?
Nov 28, 2024 · 868 followers
View post →
ひまわり No War !
@CoffeeJelly10 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Aug 10, 2024 · 66 shares · 457 followers
View post →
マサマサ
@himelbooo · X
@q6Aci2K8Jc32740 @YAT369369 @KDMCYcpefGyBUq7 @KEIZOmini3298 @Kuroi_Yahu @gaugaugauta @PLC_Kei @jisukewizon @minamiyoro @FateGinnkarasu @UlZjvKwA8UnQyH @papadenchi @PDTH3ahqRCrVri7 しかもその一つ前のポスト。タバコが感染予防になる？？な訳ないよね。リスクは喫煙でベネフィットはワクチン。https://t.co/czgFkmwsLf https://t.co/hrKoNbLyvx
Jun 11, 2024 · 4 likes · 374 followers
View post →
X
@RomanApple3 · X
@Agusia55377100 @yay_its_james https://t.co/fosDo6QclG
Apr 13, 2024 · 1,107 followers
View post →
valvane
@valvane · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Apr 11, 2024 · 66 shares · 498 followers
View post →
いくかかえるか
@tokaton17 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Apr 10, 2024 · 66 shares · 618 followers
View post →
うじー@感染対策魔人はマスク着用と科学で対処
@medical_for_all · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 20, 2024 · 66 shares · 9,182 followers
View post →
しとらす＠京都
@citrus_kyoto · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 20, 2024 · 66 shares · 1,355 followers
View post →
ぷちぐら
@80r6YUQeR7aF4ES · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 20, 2024 · 66 shares · 204 followers
View post →
ジャンボルギ～ニ酸性
@nyappiripiri · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 19, 2024 · 66 shares · 4,164 followers
View post →
シン(･∀･)デレラ
@noche_y_calima · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Oct 7, 2023 · 66 shares · 532 followers
View post →
内田
@uchida_kawasaki · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Oct 7, 2023 · 66 shares · 1,938 followers
View post →
meltypot
@meltypot · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Oct 7, 2023 · 66 shares · 1,143 followers
View post →
Suzie Jordan
@jordan_suz89305 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/5DYccorpo8
Sep 21, 2023 · 21 followers
View post →
花
@xiaolumin_ke_ai · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Aug 3, 2023 · 66 shares · 1,432 followers
View post →
ななな
@Dmiag2008 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Aug 3, 2023 · 66 shares · 4,164 followers
View post →
rbodpr
@ecodaren · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Aug 2, 2023 · 66 shares · 3,661 followers
View post →
meltypot
@meltypot · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 29, 2023 · 66 shares · 1,143 followers
View post →
Present
@jcf527 · X
@dr_cottrell Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/Xm137eDfzg
Jul 25, 2023 · 1,563 followers
View post →
blue
@__b__l__u__e___ · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 15, 2023 · 66 shares · 62 followers
View post →
michiya
@michiya19240428 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 14, 2023 · 66 shares · 2,454 followers
View post →
Myers's
@myers206 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 14, 2023 · 66 shares · 960 followers
View post →
Tomohiko EDURA
@Tomo6216jp · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 14, 2023 · 66 shares · 1,191 followers
View post →
haruo
@haruo252525 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 11, 2023 · 66 shares · 973 followers
View post →
Shinichiro HIDA
@_shinichiro_ · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jul 9, 2023 · 66 shares · 2,633 followers
View post →
とも
@tomo1982aki · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 608 followers
View post →
tani28
@tani28730 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 535 followers
View post →
Myers's
@myers206 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 960 followers
View post →
michiya
@michiya19240428 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 2,454 followers
View post →
ぷちぐら
@80r6YUQeR7aF4ES · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 204 followers
View post →
haruo
@haruo252525 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jun 25, 2023 · 66 shares · 973 followers
View post →
okamoto hiroaki
@hiroaki_okamoto · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
May 11, 2023 · 66 shares · 230 followers
View post →
MariNegishi@六甲山を歩こう！
@nyami2 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
May 11, 2023 · 66 shares · 1,467 followers
View post →
кафе@
@noble2064 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
May 9, 2023 · 66 shares · 2,053 followers
View post →
BINGOROBO collaborated by moetaxi
@moetaxi · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 24, 2023 · 66 shares · 4,104 followers
View post →
tani28
@tani28730 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 12, 2023 · 66 shares · 535 followers
View post →
宇佐美潤
@UsamiJun · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 12, 2023 · 66 shares · 3,614 followers
View post →
R
@r_hexar · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 12, 2023 · 66 shares · 385 followers
View post →
午後のお茶請け(コロナワクチン6回目接種済み)
@gogonoochauke · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 12, 2023 · 66 shares · 52 followers
View post →
babycoco
@babycoco_tw · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 7, 2023 · 66 shares · 4,369 followers
View post →
大泉洋子R
@uni_uni222 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 3, 2023 · 66 shares · 1,138 followers
View post →
haruo
@haruo252525 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 2, 2023 · 66 shares · 973 followers
View post →
しとらす＠京都
@citrus_kyoto · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 2, 2023 · 66 shares · 1,355 followers
View post →
やちよ
@8000yo · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Feb 1, 2023 · 66 shares · 476 followers
View post →
シン(･∀･)デレラ
@noche_y_calima · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 532 followers
View post →
Melaleuca
@mama_melaleuca · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 1,704 followers
View post →
Jun-ichi_Kawa
@KawatheCathand · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 3,661 followers
View post →
性格色覚Ｗ異常フニクラ@CFS＆無呼吸&HSP
@yzcyzf · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 4,002 followers
View post →
麗音
@Leonguardiangel · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 422 followers
View post →
わだにぃ 政治は生活❗️
@M9stIWtaoNqBXb9 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 1,494 followers
View post →
（・o・）
@takochu_com · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 1,533 followers
View post →
ゆりっぺ
@Pe_Ekaterina · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 678 followers
View post →
内田
@uchida_kawasaki · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 1,938 followers
View post →
ぷちぐら
@80r6YUQeR7aF4ES · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 204 followers
View post →
tani28
@tani28730 · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 535 followers
View post →
まっさん
@ta_massan · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 193 followers
View post →
ゆうさい
@you_psy · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 1,118 followers
View post →
s.j.
@uo_kawa · X
RT @ramos262740691: リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 66 shares · 243 followers
View post →
ramos2
@ramos262740691 · X
リンパ球減少症は患者の83.2%に認められる。 ま、一部のウイルス感染症では一過性に認められることがあるだろということで、長期的かどうかが次のチェックポイント https://t.co/s2GCsUy6jS
Jan 31, 2023 · 130 likes · 66 shares · 17,160 followers
View post →
GSAJournals
@GsaJournals · X
Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sYEEyrqDgI
Jan 29, 2023 · 212 followers
View post →
Minga
@revoltes · X
@GuillaumeBarucq @etatsdechoc_ https://t.co/MfNkbWvdzT
Nov 28, 2022 · 6,115 followers
View post →
Liza Tóth JD #FBPE
@ipattorneyliza · X
RT @micaki: @ipattorneyliza Opinions may contradict but data do not. We know about the lymphocytopenia induced by SARS2 already in April 2…
Nov 4, 2022 · 1 share · 4,124 followers
View post →
mitsaki - protect the
@micaki · X
@VPrasadMDMPH Or maybe is someone following the data since the beginning of the pandemic, like this one (April 2020): "Lymphocytopenia was present in 83.2% of the patients on admission." https://t.co/PGCMS2ezPO
Nov 4, 2022 · 2 likes · 133 followers
View post →
mitsaki - protect the
@micaki · X
@ipattorneyliza Opinions may contradict but data do not. We know about the lymphocytopenia induced by SARS2 already in April 2020 (and we also knew the consequences of SARS1...) "Lymphocytopenia was present in 83.2% of the patients on admission." https://t.co/PGCMS2ezPO
Nov 4, 2022 · 1 like · 1 share · 133 followers
View post →
sigrid pforr
@siggi2106 · X
RT @micaki: @RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore t…
Oct 24, 2022 · 4 shares · 139 followers
View post →
mitsaki - protect the
@micaki · X
@danaparish We all knew that SARS2 is debilitating. We knew what SARS was doing in 2003 and data about SARS2 were published in April 2020: "Lymphocytopenia was present in 83.2% of the patients on admission." https://t.co/PGCMS2ezPO
Oct 24, 2022 · 3 likes · 133 followers
View post →
Amy Kartheiser
@kartham12 · X
RT @micaki: @RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore t…
Oct 24, 2022 · 4 shares · 231 followers
View post →
Khadija
@khadijakamala · X
RT @micaki: @RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore t…
Oct 23, 2022 · 4 shares · 2,259 followers
View post →
Kathy McCarty
@KMTBERRY · X
RT @micaki: @RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore t…
Oct 23, 2022 · 4 shares · 1,370 followers
View post →
mitsaki - protect the
@micaki · X
@RWittenbrink It was clear since the beginning, that SARS2 is causing lymphocytopenia. Our leadership just decided to ignore the data and pretend all will fine. China, April 2020: "Lymphocytopenia was present in 83.2% of the patients on admission." https://t.co/PGCMS2ezPO
Oct 23, 2022 · 30 likes · 4 shares · 133 followers
View post →
IvoDePivo
@de_pivo · X
@Marc_Veld @denkentutweh @origincanada @Amal4Solutions @Yash25571056 @KasperKepp @NGrandvaux I never said sc2 causes lymphocytopenia. I don’t know if it does. Like with much in this pandemic, we’ll see. Quick search: seems like there are hints it may. https://t.co/8IjmsdiTWS. https://t.co/LPbrYXBsPf
Oct 5, 2022 · 425 followers
View post →
pablo mg
@pablotopo · X
RT @ignace: @mipardudire @carlostph Aquí el estudio chino y destacado el párrafo sobre el método: https://t.co/ob2vWFRAOZ https://t.co/nC6w…
Sep 17, 2022 · 1 share · 1,113 followers
View post →
Anil Makam
@AnilMakam · X
Here is just one of many case series describing our shared experience https://t.co/YJj1kJ8JzJ https://t.co/QzRymOTGtX
Sep 12, 2022 · 4 likes · 6,845 followers
View post →
edge , corner of circle
@edgeofcircle · X
RT @koureiigaku: 背景 COVID-19は全世界で何百万人もの死者をもたらし、健康危機を引き起こしました。軽症から重症まで様々ですが、最も一般的な重症病型はARDSを伴う肺炎です*。 https://t.co/GFDVd49pPx
Aug 18, 2022 · 2 shares · 1,092 followers
View post →
Jun-ichi_Kawa
@KawatheCathand · X
RT @koureiigaku: 背景 COVID-19は全世界で何百万人もの死者をもたらし、健康危機を引き起こしました。軽症から重症まで様々ですが、最も一般的な重症病型はARDSを伴う肺炎です*。 https://t.co/GFDVd49pPx
Aug 18, 2022 · 2 shares · 3,661 followers
View post →
UMA / PHI E推 / Listenbourg出身
@UMA_Love_Y · X
RT @koureiigaku: 背景 COVID-19は全世界で何百万人もの死者をもたらし、健康危機を引き起こしました。軽症から重症まで様々ですが、最も一般的な重症病型はARDSを伴う肺炎です*。 https://t.co/GFDVd49pPx
Aug 17, 2022 · 2 shares · 1,464 followers
View post →
Konstantin Grachev
@kograt · X
@Ashmedaidemon Here is old one from April 2020. All the Asians I know are smokers and used to know about it. virus just dies in nuclear apocalypse landscape of our lungs. https://t.co/HHSMkUCxM2
Aug 16, 2022 · 451 followers
View post →
tanz mit mir
@tanzmitmir01 · X
RT @canchemistry: そもそも、新型コロナウイルスは発症初期に発熱しない患者が多いとされています。 発熱があったのは、DP号（ダイヤモンド・プリンセス号、104例）では約30%、武漢の症例（1099例、ただし入院当初）では約44%とされています。 DP号（表も）…
Aug 2, 2022 · 111 shares · 297 followers
View post →
PSIQUIATRÍA INPRFM
@INPRFM · X
Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://t.co/QeqcQZ7y6t
Jul 29, 2022 · 40,631 followers
View post →
koureiigaku
@koureiigaku · X
背景 COVID-19は全世界で何百万人もの死者をもたらし、健康危機を引き起こしました。軽症から重症まで様々ですが、最も一般的な重症病型はARDSを伴う肺炎です*。 https://t.co/GFDVd49pPx
Jul 22, 2022 · 6 likes · 2 shares · 853 followers
View post →
Jordan James Etem
@JordanJamesEtem · X
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720 #COVID19
Jun 17, 2022 · 12,663 followers
View post →
GoTO
@GtoDr · X
@Shuntarooo3 僕が紹介してたのはこれですかね https://t.co/td5Is7E5VM
Apr 22, 2022 · 6 likes · 5,137 followers
View post →
PSIQUIATRÍA INPRFM
@INPRFM · X
Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://t.co/QeqcQZ7y6t
Jan 4, 2022 · 40,631 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
https://t.co/YmVdVJPjRI
Jan 4, 2022 · 1 like · 37 followers
View post →
Adolfo Calvo-Parra Martínez
@adolfCP · X
@CancerIntegral @juanquiles La realidad es que desde Abril de 2020 ya se describió al COVID19 como una enfermedad que podría afectar a todos los rangos de edad. Eso de decir que no ha habido casos de COVID19 en niños, es mentira. https://t.co/hRYUps1s26
Dec 8, 2021 · 818 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/YmVdVJPjRI
Dec 8, 2021 · 1 like · 37 followers
View post →
Bruja
@BentsCristin · X
@gulliver_77 @NDRinfo https://t.co/Q7vqqEuIa0 Etwas gefährdeter sind kleinere Kinder zwischen einem und fünf Jahren; sie haben in sieben bis zehn Prozent der Fälle einen moderaten oder schweren akuten Infektionsverlauf.4,5 https://t.co/kYHMZniaNx https://t.co/zaLjmgcdp8
Aug 24, 2021 · 5 likes · 7,319 followers
View post →
yohiverse
@yohiverse · X
https://t.co/N37zgWd7GY
Aug 2, 2021 · 1,590 followers
View post →
Yogui
@Yogui6664 · X
@razeprnrm @Le___Doc J'ai trouvé D'après une étude 62 % des patients covid sont des hommes Mais votre chiffre n'est peut-être pas le bon... Source : https://t.co/uy9Vg4VF42
Jul 14, 2021 · 1,179 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/4lWQs33YmA
Jun 17, 2021 · 1 like · 37 followers
View post →
Fabrice FRANK
@fabrice_frank · X
Cela pourrait être interprété comme un lien entre la transmissibilité et le spectre des manifestations cliniques. Si tel est le cas, leur référence qui détaille les caractéristiques cliniques du Covid-19 ne vient pas étayer cette affirmation. https://t.co/Mxdlqxq5oB
Jun 5, 2021 · 4 likes · 1,329 followers
View post →
Fabrice FRANK
@fabrice_frank · X
Dans le même but, ils utilisent la référence 19 : https://t.co/CooCcTm78b
Jun 5, 2021 · 4 likes · 1,329 followers
View post →
Dmitry Medvedev
@DmitryMedv · X
@pkasyanov_wos Вот несколько работ за период с 2020 г по н.в. https://t.co/Ttv7ZliEBc, https://t.co/pq9UGsdhFH, https://t.co/C4t59vlbFE https://t.co/GwRsHF75Ku https://t.co/nVxji8jZVo .
May 31, 2021 · 939 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/OHT0opkyLC
May 20, 2021 · 1 like · 37 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
https://t.co/CPiKeYVGdJ
Apr 20, 2021 · 1 like · 37 followers
View post →
Mary Prante, PhD
@MaryPrante · X
ICYMI https://t.co/rx8IoPuWu5 https://t.co/RTQz1G67SS
Apr 18, 2021 · 216 followers
View post →
Mary Prante, PhD
@MaryPrante · X
RT @MaryPrante: https://t.co/rx8IoPuWu5 https://t.co/ITIxpi9fds
Apr 17, 2021 · 1 share · 216 followers
View post →
Mary Prante, PhD
@MaryPrante · X
https://t.co/rx8IoPuWu5 https://t.co/ITIxpi9fds
Apr 16, 2021 · 1 like · 1 share · 216 followers
View post →
Mary Prante, PhD
@MaryPrante · X
RT @MaryPrante: ICYMI https://t.co/rx8IoPuWu5 https://t.co/TLUi48Q3tJ
Apr 13, 2021 · 1 share · 216 followers
View post →
Mary Prante, PhD
@MaryPrante · X
ICYMI https://t.co/rx8IoPuWu5 https://t.co/TLUi48Q3tJ
Apr 12, 2021 · 1 like · 1 share · 216 followers
View post →
Isatou Sarr
@IsatouSarr4 · X
During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. https://t.co/YmVdVJPjRI
Mar 29, 2021 · 1 like · 37 followers
View post →
MICHAEL
@DRMBYRNES · X
We know where the Wuhan China flu came from. Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/uwz8pEt21D
Feb 9, 2021 · 2,316 followers
View post →
MOIZ ESUFALLY
@moizesufally · X
https://t.co/iG95ZDDLFs
Feb 5, 2021 · 351 followers
View post →
CIMSA-BEM KM FK Unand
@cimsaunand · X
The aforementioned Guan et al study, “Clinical Characteristics of Coronavirus Disease 2019 in China” shows that compared to non-smokers, smokers are 2.4 times more likely to be admitted to an intensive care unit, need mechanical ventilation or die.
Jan 19, 2021 · 1,255 followers
View post →
Grenepenis
@grenepenis · X
COVID-19 Symptoms: Is a Headache an Early Sign of the Virus? https://t.co/uXozgiZsAb via @heavysan WHY POST A CHART OF "Clinical Characteristics of Coronavirus Disease 2019 in China" WITHOUT LABELING THE COLUMNS OF DATA? IT IS UTTERLY MEANINGLESS WITHOUT THESE LABELS.
Dec 5, 2020
View post →
ToFreedom
@KALFreedom · X
RT @MichaelPSenger: 2/ First source cited in @WHO's COVID testing guidance: https://t.co/CYTqdSot8R Second source cited in @WHO's testing…
Nov 17, 2020 · 2 shares · 198 followers
View post →
“Experts” = The Approved Narrative
@TsicsafPelosi · X
RT @MichaelPSenger: 2/ First source cited in @WHO's COVID testing guidance: https://t.co/CYTqdSot8R Second source cited in @WHO's testing…
Nov 17, 2020 · 2 shares · 1,693 followers
View post →
Michael P Senger
@michaelpsenger · X
2/ First source cited in @WHO's COVID testing guidance: https://t.co/CYTqdSot8R Second source cited in @WHO's testing guidance (PCR cycle thresholds in appendices): https://t.co/5sqxRqe83v https://t.co/zs60vNK3CN
Nov 17, 2020 · 17 likes · 2 shares · 167,921 followers
View post →
Ivy
@ITR31 · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/BFuzkzLU3r via @YouTube
Nov 5, 2020 · 11 followers
View post →
Jim Cavet
@CavetJim · X
@alwaystheself https://t.co/TESk0604Uj Feb 9th (subsequently @NEJM https://t.co/qyagHoM3pA)
Oct 10, 2020 · 511 followers
View post →
GR
@Gypsyro61119233 · X
[The New England Journal of Medicine] Clinical Characteristics of Coronavirus Disease 2019 in China - Fight Covid-19 they knew in 2019 why wasn’t it reported https://t.co/1Rali05Diu
Oct 8, 2020 · 23 followers
View post →
Dr. Antonio Gutiérrez
@boticariors · X
Y las manifestaciones oculares de la #COVID19 no son precisamente banales ni infrecuentes, pudiendo usar este canal para causar infección respiratoria https://t.co/r4aQq5IAIU https://t.co/PsUaGJKMaE https://t.co/3a9dD8Z1qs https://t.co/H0jvBMgZXN
Sep 20, 2020 · 11,176 followers
View post →
momo noki
@momo_ni · X
RT @Kentauros2H: 加藤厚労大臣様 日本感染症学会長様、東北薬科大学教授様② ☟NEJM掲載 ｢Clinical Characteristics of Coronavirus Disease 2019 in China｣ https://t.co/KDa9whyO…
Sep 15, 2020 · 4 shares · 2,671 followers
View post →
مروری بر کووید-۱۹
@Covid19_Review · X
۵۸/ پوست: بافت دیگر بدن که به نظر میرسد تحت تاثیر عفونت #کووید۱۹ قرار میگیرد، پوست است. در یک مطالعه که در ۲۸ فوریه و بین بیش از ۱۰۰۰ بیمار در چین انجام گرفت، بثورات پوستی در ۰.۲٪ بیماران مشاهد شد. https://t.co/YheVc1E4hd https://t.co/x14Ev93vHJ
Sep 5, 2020 · 55 followers
View post →
مروری بر کووید-۱۹
@Covid19_Review · X
۳۷/ تهوع، استفراغ و اسهال ممکن است جزو علائم اولیه بوده و حتا قبل از شروع تب یا علائم تنفسی رخ دهند، که باید به عنوان پیش علامت احتمالی در عفونت #کووید۱۹ در نظر گرفته شوند. https://t.co/pgqr3pUTpO https://t.co/nH0pHd2P7C https://t.co/oSPymN1jog https://t.co/9gSQZOqQ39
Sep 5, 2020 · 55 followers
View post →
david
@david07922343 · X
@DrEricDing @trishgreenhalgh We’ve known Covid-19 severity & symptomatic risk since December (Guan, 2019) Policymakers haven’t done enough Social media influencers don’t know what high risk means https://t.co/pMH6NCJ0SC
Aug 31, 2020 · 10 followers
View post →
Josette Schoenmakers
@JosetteSchoenma · X
@ginnymooy Even de source opgezocht. Gepubliceerd op 28 februari 2020. "Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM" https://t.co/ToqJLZBKEN
Aug 6, 2020 · 4 likes · 1 share · 6,768 followers
View post →
ruby e. mcsherdon
@McsherdonRuby · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/JWC4dX8zig via @YouTube
Jul 21, 2020 · 82 followers
View post →
Paulina
@lpaulina85 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/4ZPEOoLZOt
Jul 20, 2020 · 34 followers
View post →
たれぱんだのこ
@oIUnHakVW5CJVwy · X
RT @Kentauros2H: 加藤厚労大臣様 日本感染症学会長様、東北薬科大学教授様② ☟NEJM掲載 ｢Clinical Characteristics of Coronavirus Disease 2019 in China｣ https://t.co/KDa9whyO…
Jul 18, 2020 · 4 shares · 195 followers
View post →
偽トノイケ☆ダイスケ@BIとJGPクラスタ捜査中
@gannbattemasenn · X
RT @Kentauros2H: 加藤厚労大臣様 日本感染症学会長様、東北薬科大学教授様② ☟NEJM掲載 ｢Clinical Characteristics of Coronavirus Disease 2019 in China｣ https://t.co/KDa9whyO…
Jul 18, 2020 · 4 shares · 1,488 followers
View post →
怒りのアビガン
@C5H4FN3O2 · X
RT @Kentauros2H: 加藤厚労大臣様 日本感染症学会長様、東北薬科大学教授様② ☟NEJM掲載 ｢Clinical Characteristics of Coronavirus Disease 2019 in China｣ https://t.co/KDa9whyO…
Jul 18, 2020 · 4 shares · 1,534 followers
View post →
kentauros2HAL9000
@Kentauros2H · X
加藤厚労大臣様 日本感染症学会長様、東北薬科大学教授様② ☟NEJM掲載 ｢Clinical Characteristics of Coronavirus Disease 2019 in China｣ https://t.co/KDa9whyOFt
Jul 18, 2020 · 7 likes · 4 shares · 1,051 followers
View post →
Beata
@JakSolB · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/xUEFpqzX7s
Jun 20, 2020 · 1,451 followers
View post →
Rodrigo Carqueijeiro
@Carqueijeiro · X
Segundo estudo chinês publicado no NEJM, na população chinesa em que se tem cerca de 29% de tabagistas, entre pacientes COVID-19 a prevalência é de 12,3%. Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/guFcVpJfTE
Jun 16, 2020 · 162 followers
View post →
おおえ☆よしひろ
@tyaya9822 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/xfYvqtLJrM
Jun 10, 2020 · 2,578 followers
View post →
MediSci
@HippocraL · X
@HemeReview @choo_ek @chubbyemu GREAT explanation of the CORONA VIRUS from diagnosis in Wuhan to present https://t.co/CJUNNRu6Xz
Jun 3, 2020 · 83 followers
View post →
DR. RODOLFO PALENCIA
@DrPalencia · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM #COVID__19 https://t.co/mHWY1oLQfG
May 20, 2020 · 441 followers
View post →
Phil K
@Hi5_Phil · X
@BS_753 @HerbertLackner1 @heimolepuschitz https://t.co/Pj7mijQnJ1
May 20, 2020 · 3 likes · 2,096 followers
View post →
AsemSnoubar
@AsemSnoubar · X
@DrTariqMadouh @salrashed في ورقة علمية وصلت لنتائج تؤكد ان سرعة انتشار المرض تختلف عن باقى الامراض الموسمية Clinical characteristics of coronavirus disease 2019 in China
May 14, 2020 · 96 followers
View post →
Neuropediatrics®️
@NeuroInfanti · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/2nrB8sDjiK
May 11, 2020 · 2,078 followers
View post →
Hedley Quintana MD, MSc, PhD
@hedleyquintana · X
@PophamFrank @VardavasC @reinaro The paper of the Chinese preprint DOES NOT include the model!!! The reviewers noticed the overadjustment and they suggested the authors deleting it from the paper! Preprint: https://t.co/SwZJKLeGwE Published paper: https://t.co/DJFajlpnzT
May 10, 2020 · 295 followers
View post →
iamjacks
@oldberserk · X
4/ Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708.Wu C, Chen X, Cai Y, et al.
May 8, 2020 · 72 followers
View post →
Tui22
@InfoInterest · X
Clinical Characteristics of Coronavirus Disease 2019 in China [A retrospective study of 1,099 cases of lab confirmed #Covid19 in China] https://t.co/If2U2ai6kP https://t.co/DOH6WHglha
May 8, 2020 · 226 followers
View post →
いやんみちゃだめ
@ijanmicxadame · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 358 followers
View post →
makotokasai
@makotokasai · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 2,851 followers
View post →
Masato Ida, PhD
@miakiza20100906 · X
その中国の新型コロナの論文、Google Scholar 調べで既に 2000 回以上も引用されている。2000 本を追いかけるのは無理だな…。 https://t.co/ulAFAhRGwf
May 6, 2020 · 3 likes · 1 share · 8,050 followers
View post →
N/A
@baby_mantis · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 62 followers
View post →
YYC Correspondence（人民の端くれ）
@YYCCorres · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 341 followers
View post →
Masato Ida, PhD
@miakiza20100906 · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 8,050 followers
View post →
真田 正夫/サタン(世も末)
@sanadian_dadd · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 530 followers
View post →
もんと【被ばく、いらない！】
@mon1ten2 · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 926 followers
View post →
ルイージ
@SmHFFaOh92cBtWd · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 153 followers
View post →
okugee
@okugee · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 1,213 followers
View post →
huga
@hugu2323 · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 1,376 followers
View post →
横川圭希
@keiki22 · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 29,735 followers
View post →
彫木
@CordwainersCat · X
RT @miakiza20100906: 論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMa…
May 6, 2020 · 12 shares · 4,285 followers
View post →
Masato Ida, PhD
@miakiza20100906 · X
論文（無料・査読後）はこれのよう： 中国での新型コロナの臨床的特徴 Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/sXrmTMafzw 2020年、Guan（広州医科大学／中国）ら。中国の552病院、計1099人の患者の特徴について。
May 6, 2020 · 18 likes · 12 shares · 8,050 followers
View post →
寄り道
@edgeofstreet918 · X
@ShinShinohara 此方に診察の手引きがあります。 https://t.co/GFAHGzVC5S 血液検査の根拠に関しては此方を。 https://t.co/YouBwCJQJi CTスキャン診断は此方です。 https://t.co/Bkqw3jrk4m 抗体検査は此方の記事を。 https://t.co/CCtRwx64Fr https://t.co/MslYCmxYyh
May 4, 2020 · 5 likes · 4,686 followers
View post →
rintaro
@rinaro0528 · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
May 3, 2020 · 35 shares · 344 followers
View post →
Захар
@Zakhar_Puzyrkov · X
@novikov_404 @mediazzzona Почитайте вы научные статьи. Всё люди подвержены заражению. [данные из статьи Clinical Characteristics of Coronavirus Disease 2019 in China, New England Journal of Medicine (2020)] https://t.co/UsaBzh9lyf
May 1, 2020 · 4 followers
View post →
Luiz Aguila
@LuizAguila · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/tOOiEXmS2m
Apr 30, 2020 · 18 followers
View post →
Ernesto Rodríguez H
@ernestocardio · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/P2bLvKoEEo
Apr 30, 2020 · 2,214 followers
View post →
Sergio Casas Tintó
@Checho_casas · X
Clinical Characteristics of Coronavirus Disease 2019 in China https://t.co/Q1aDFT6FVo
Apr 30, 2020 · 1,125 followers
View post →
CJ Neal
@CJNeal11 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/lxh6e8AJuE
Apr 29, 2020 · 18 followers
View post →
Захар
@Zakhar_Puzyrkov · X
Статья: Clinical Characteristics of Coronavirus Disease 2019 in China, New England Journal of Medicine (2020)
Apr 26, 2020 · 4 followers
View post →
Clau Parra
@clauparrag11 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/lpaU8h2USw
Apr 26, 2020 · 273 followers
View post →
s4zero
@windows_update · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 24, 2020 · 35 shares · 425 followers
View post →
Kiosque de Paris
@KiosqueDeParis · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/AayXKM5HY4
Apr 24, 2020 · 129 followers
View post →
jacaranda200
@jacaranda08 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/gv7s6ABnRo
Apr 23, 2020 · 18 followers
View post →
K
@Caspelouro · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/lnPtE0Cmpz
Apr 22, 2020 · 154 followers
View post →
Pragmatic Rebel
@_PragmaticRebel · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 22, 2020 · 35 shares · 18 followers
View post →
Fabian Nuñez Acosta
@delzonda · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 20, 2020 · 35 shares · 729 followers
View post →
Beatriz ✝️
@Beatrocito · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 20, 2020 · 35 shares · 607 followers
View post →
Metralla
@Metrall47270341 · X
RT @PedroPiraino: Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/VpXi3iCgHf
Apr 20, 2020 · 1 share · 316 followers
View post →
Squidward
@eur0trashbarbie · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 20, 2020 · 35 shares · 40 followers
View post →
泥んこ (おとなの泥んこ遊びの会)
@KyotoSotai · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 18, 2020 · 35 shares · 94 followers
View post →
durand benoit
@benoit_durand · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 18, 2020 · 35 shares · 2,065 followers
View post →
Norbert Zillatron
@N_Zillatron · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 18, 2020 · 35 shares · 3,585 followers
View post →
Serdar Uysal
@radikulum · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 16, 2020 · 35 shares · 18 followers
View post →
Serhat
@DemarAver · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Apr 16, 2020 · 35 shares · 69 followers
View post →
Bgraceful905/Ms.Colson
@bgraceful905 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/rsa1nS67NF
Apr 16, 2020 · 40 followers
View post →
Sue Harding
@Chavender · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 16, 2020 · 24 shares · 1,422 followers
View post →
Erwin Rommel
@bigx1 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 630 followers
View post →
AsgarShaik7599
@AsgarShaik7599 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 1,306 followers
View post →
Alfons López Tena
@alfonslopeztena · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 188,453 followers
View post →
Pdog
@LynnParkPDog · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 495 followers
View post →
Muharrem Dönmez
@muharremdonmezz · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 904 followers
View post →
MichaelSambogna
@MichaelSambogna · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 2,571 followers
View post →
Ibbo
@abrahamgmr · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 691 followers
View post →
Anne Marie Flynn
@AnneMarieFlynn2 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 4,008 followers
View post →
maribel
@maribeljm21 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 235 followers
View post →
helen_hoops
@helen_hoops · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 1,756 followers
View post →
.
@JyotiKr66393068 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 1,630 followers
View post →
David Moloney
@cto_maverick · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 5,901 followers
View post →
MC1
@thack86 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 2,054 followers
View post →
Téa Smith
@tealou · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 6,162 followers
View post →
Carol
@mywordsworlds1 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/PZb5YwX2uO
Apr 15, 2020 · 5,218 followers
View post →
Cosasdesolohoy
@cosasdemanana · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 1,411 followers
View post →
Finbarfin
@finbarfin · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 3,305 followers
View post →
Your_high_dose
@Your_high_dose · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 14,889 followers
View post →
W. Meadowbrook♿
@WaterflowerM · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 6,796 followers
View post →
Tariq Alvi ووٹ کو عزت دو۔
@TariqAlvi18 · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 2,069 followers
View post →
Fira Braja Brata Atmaja
@Dennaaja_ · X
RT @alfonslopeztena: Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients,…
Apr 15, 2020 · 24 shares · 2,383 followers
View post →
Alfons López Tena
@alfonslopeztena · X
Clinical Characteristics of Coronavirus Disease 2019 in China — lymphocytopenia was present in 83.2% of the patients, thrombocytopenia in 36.2%, and leukopenia in 33.7%. Most of the patients had elevated levels of C-reactive protein https://t.co/xHoS7YZPi5
Apr 15, 2020 · 30 likes · 24 shares · 188,453 followers
View post →
Bob Knox
@rdk4558 · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM-are sick patients getting cor pulmonale quicker due to diffuse intravascular thrombotic events? Should sick patients be heparinized? https://t.co/ZX5ovPYusr
Apr 14, 2020 · 6 followers
View post →
Bisanth Batuwitage
@surfindoc · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 477 followers
View post →
Hans Huitink
@AirwayMxAcademy · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 14,316 followers
View post →
FOAMed
@ANEIVASOS · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 639 followers
View post →
Emma Young
@dremmayoung · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 1,161 followers
View post →
Carley BB
@bowmacEM · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 261 followers
View post →
BeyondyoursiteHeals
@BeyondyoHeals · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 3 followers
View post →
@JuanpaElProfeee
@juanpaesculapio · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 1,230 followers
View post →
Segun Olusanya (He/Him) iceman_ex@critcare.social
@iceman_ex · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 19,586 followers
View post →
Rick Body
@richardbody · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 8,113 followers
View post →
Andy Cooper ARRC
@andycooper01 · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 681 followers
View post →
Professor Andrew Rowland OBE CF FRCPCH
@DrAndrewRowland · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 3,433 followers
View post →
Husam
@me_EM_sam · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 442 followers
View post →
SWBH_ED
@SWBH_ED · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 679 followers
View post →
Erika Panaro
@ErikaPanaro · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 1,748 followers
View post →
Wishaw General ED
@wishydocs · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 1,732 followers
View post →
Michael
@MikeGatMe · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 87 followers
View post →
Dr Pushkin Roy
@RoyPushkin · X
RT @EMManchester: Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://…
Apr 14, 2020 · 25 shares · 105 followers
View post →
Prof Simon Carley
@emmanchester.bsky.social · Bluesky
Papers for Covid19 journal club today Main paper: Clinical Characteristics of Coronavirus Disease 2019 in China https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
Apr 14, 2020 · 1 share
View post →
sıkıntı büyük
@zubartan · X
@dmuratturkmen @CaKizil Çok tşk. Ancak vaka seyrine etkisi çalışmada yok. En çok vakayı içeren araştırmaya baktım, orada önceden içenler ve halen içenlerin vaka seyrin biraz daha kötü seyrettiği görülebiliyor. + https://t.co/A4MIDZLFBl
Apr 12, 2020 · 1 like · 1,211 followers
View post →
Xavi Cano
@XaviCano84 · X
Aprendiendo sobre medicamentos y el covid. La info relacionada puede cambiar con el tiempo, según lo advierte su autor. https://t.co/pFWakLfMmc
Apr 11, 2020 · 13 followers
View post →
EPUIG
@eepuig · X
RT @apuigmd: Hola, este material es de interés para los pacientes y la comunidad en general ante la pandemia COVID-19 https://t.co/qQ6mmulk…
Apr 10, 2020 · 2 shares · 25 followers
View post →
Jorge M Patarroyo
@jmpatarroyo · X
RT @apuigmd: Hola, este material es de interés para los pacientes y la comunidad en general ante la pandemia COVID-19 https://t.co/qQ6mmulk…
Apr 10, 2020 · 2 shares · 166 followers
View post →
Alvaro Puig
@apuigmd · X
@fernandomillan @PelusaCaramba @AlvaroGarciaJ @chucurena @leylaponcedleon @ErikaFontalvo @MariaMatusv @SrtaBovary @IsabelSalazarJ @albertomedinal @AdrianaLucia Hola, este material es de interés ante COVID-19, por favor compártanlo https://t.co/qQ6mmulkaL
Apr 10, 2020 · 2 likes · 71 followers
View post →
Alvaro Puig
@apuigmd · X
Hola, este material es de interés para los pacientes y la comunidad en general ante la pandemia COVID-19 https://t.co/qQ6mmulkaL
Apr 10, 2020 · 5 likes · 2 shares · 71 followers
View post →
Gary Weissman
@garyweissman · X
Regardless of the underlying model, none of these approaches translate case counts into numbers of hospital or ICU beds, or ventilators, so we relied on published case series out of China and Italy, https://t.co/lJ4svDbpke https://t.co/lUVbEyTwyh https://t.co/1NivS59nEx /9
Apr 7, 2020 · 4 likes · 1,371 followers
View post →
Amethystinia, ✨
@Amethystinia · X
RT @LaLoca228: I'm gonna link up the early studies that came out of China. Some were not peer reviewed at that time One case showed sympto…
Apr 4, 2020 · 3 shares · 747 followers
View post →
Kavi
@KazGirl20 · X
RT @LaLoca228: I'm gonna link up the early studies that came out of China. Some were not peer reviewed at that time One case showed sympto…
Apr 4, 2020 · 3 shares · 2,739 followers
View post →
⎊Su⎊
@LaLoca228 · X
I'm gonna link up the early studies that came out of China. Some were not peer reviewed at that time One case showed symptoms after 24 days but a median of 3 days https://t.co/eemhwqcj8Q
Apr 4, 2020 · 1 like · 3 shares · 750 followers
View post →
John Cosgrove FRCGP
@DrJohnCosgrove · X
I am disappointed that this was probably neither written by the Chinese doctors named nor published by @NEJM. An important finding nonetheless! (Cf. the cited article https://t.co/46e6FZTKdj ) https://t.co/UAKTTbip3i
Apr 4, 2020 · 1 like · 4,110 followers
View post →
Institute for Addiction Science at USC
@IASatUSC · X
People who smoke are 2.4 times more likely to be admitted to the ICU, need a ventilator or die from #COVID-19 compared to those who do not #smoke, according to a study published by the New England Journal of Medicine. #NEJM #coronavirus #tobacco https://t.co/4zrxoTsZl1
Mar 31, 2020 · 1,695 followers
View post →
Dr CL Wright
@DrCLWright · X
@peterwalker99 https://t.co/16bpIViA9a https://t.co/n7epJNtShi https://t.co/ZFkxfYpzRl
Mar 31, 2020 · 888 followers
View post →
blabber_candy
@CynicCandy · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 31, 2020 · 38 shares · 30 followers
View post →
Alexandre Niset
@UneFriteUneFois · X
10/ …poids et son statut supposé dans les analyses ; Devenir clinique (besoin d’O2 : 15%, transfert USI : 3.8%, décès 1.2%) comparable aux études de groupes non traités (https://t.co/U56CazYpYO) ; 18 patients (22.5%) ayant bénéficié d’un traitement antibiotique…
Mar 30, 2020 · 643 followers
View post →
Ivanna_
@VapinSquirrel · X
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Mar 29, 2020 · 35 shares · 1,679 followers
View post →
DoctorBobby
@DrBobbyOficial · X
#Covid_19 SIGNOS, SÍNTOMAS Y QUE HACER!! (Evidencia científica) Conoce quienes son las personas en mayor riesgo. #coronavirus #QuedateEnCasa #CuarentenaCoronavirus #COVID #COVID19 https://t.co/zczG633c55
Mar 28, 2020
View post →
Ade Sunarma
@sunarmaID · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 28, 2020 · 38 shares · 645 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@salomondrin @salomondrin revisa estos vídeos que estoy haciendo con evidencia científica del #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes están mayor riesgo Y COMO DEBEMOS DE ACTUAR https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@salomondrin @jucaviapri @elonmusk #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@jucaviapri #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@GobiernoMX #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@GobiernoMX @ISSSTE_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@ISSSTE_mx @SusanaDistancia #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@ISSSTE_mx @SusanaDistancia #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@Tu_IMSS #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@HLGatell @SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@HLGatell @SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@HLGatell #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@idanielth @HLGatell @GobiernoMX #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@gorez1 #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@CoronaVirus__Mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@MxOtros #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@lopezdoriga #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@lopezdoriga #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@CiroGomezL @SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@sopitas #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@sopitas #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@GobiernoMX @SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@politicomx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@lopezdoriga #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@NlSalud #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@SSalud_mx #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@SSalud_mx @SusanaDistancia #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@AristeguiOnline #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@DeniseDresserG #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@Claudiashein @DeniseDresserG #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@CNNMex @aristeguicnn #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@aristeguicnn #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@CNNEE @aristeguicnn @drhuerta @Spotify @ApplePodcasts #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@AristeguiOnline #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@AristeguiOnline #Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 1 like · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
#Covid_19 ¡Conoce los SIGNOS, SÍNTOMAS Y QUÉ HACER! (Evidencia científica) Revisamos artículos científicos para enseñarte quiénes son las personas en mayor riesgo Y COMO DEBEMOS DE ACTUAR. #COVID2019 #QuedateEnCasa #SARSCoV #CuarentenaObligatoria https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@Milenio #Covid_19 Conoce los SIGNOS, SÍNTOMAS Y QUE HACER!! (Evidencia científica) Conoce quienes son las personas en mayor riesgo gracias a la evidencia científica https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
Doctor Bobby
@ImDoctorBobby · X
@SSalud_mx #Covid_19 Conoce los SIGNOS, SÍNTOMAS Y QUE HACER!! (Evidencia científica) Conoce quienes son las personas en mayor riesgo gracias a la evidencia científica https://t.co/x78WzSuPAR
Mar 28, 2020 · 62 followers
View post →
luss
@Suldarmawan · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 27, 2020 · 38 shares · 125 followers
View post →
Brenda Carbajal S.
@oncocarbajal · X
Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://t.co/wlGCLWcRDh
Mar 25, 2020 · 90 followers
View post →
Xїla
@xxxila · X
@Sharon_ACox @TC_BMJ @bmj_latest Sorry for the nonsmokers who clearly are the more vulnerable group this time: https://t.co/0c5YmWoNji
Mar 25, 2020 · 2 likes · 6 followers
View post →
Keni Vidilaseris
@kenividilaseris · X
RT @sains_pop: Apa sih gejala COVID-19? . . Sumber: Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristicsof coronav…
Mar 25, 2020 · 3 shares · 135 followers
View post →
علوان دارالسلام
@alwanads · X
RT @sains_pop: Apa sih gejala COVID-19? . . Sumber: Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristicsof coronav…
Mar 25, 2020 · 3 shares · 233 followers
View post →
SainsPop
@sains_pop · X
Apa sih gejala COVID-19? . . Sumber: Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristicsof coronavirus disease 2019 in China. N Engl J Med. 2020. https://t.co/t1ruImzWyM . . #sains #sainspop #sainspopuler #sainspopular #infosai… https://t.co/e9QpDCAKOV https://t.co/yoYFtNam9r
Mar 25, 2020 · 2 likes · 3 shares · 414 followers
View post →
Nan
@KinanCondro · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 25, 2020 · 38 shares · 22 followers
View post →
holid darussalam
@holiddarussalam · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 374 followers
View post →
Victor
@victorlbrum · X
RT @PulmCrit: if we dig deeper into the Guan study, we see that some patients with more severe disease *do* have procalcitonin elevation
Mar 24, 2020 · 6 shares · 162 followers
View post →
Mangdani
@dannydhe · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 4,603 followers
View post →
Natasha MD
@Natasha_ICU · X
RT @PulmCrit: if we dig deeper into the Guan study, we see that some patients with more severe disease *do* have procalcitonin elevation
Mar 24, 2020 · 6 shares · 17 followers
View post →
Mohammed Mar'ae Asiri
@Asiritrauma1 · X
RT @PulmCrit: if we dig deeper into the Guan study, we see that some patients with more severe disease *do* have procalcitonin elevation
Mar 24, 2020 · 6 shares · 18,236 followers
View post →
Mario Hernandez
@monohernandez · X
RT @PulmCrit: if we dig deeper into the Guan study, we see that some patients with more severe disease *do* have procalcitonin elevation
Mar 24, 2020 · 6 shares · 1,710 followers
View post →
PulmCrit
@PulmCrit · X
if we dig deeper into the Guan study, we see that some patients with more severe disease *do* have procalcitonin elevation
Mar 24, 2020 · 16 likes · 6 shares · 63,736 followers
View post →
Surya Borneo
@SuryaBorneo · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 2,199 followers
View post →
荻野寿美子
@sinzan_yukoku · X
@Dorothy7si @kasajei @IHayato https://t.co/8WR3Lnl45H https://t.co/eAQLEWmAfg
Mar 24, 2020 · 1 like · 1,098 followers
View post →
RH15
@RiskaHayuti · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 171 followers
View post →
Aldi Sinuhaji
@AldiSinuhaji · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 128 followers
View post →
rahung
@rahung · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 197,033 followers
View post →
禰
@dyahisla · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 773 followers
View post →
sudiarto
@akunsudi · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 1,407 followers
View post →
Arma Dion
@arm4di0n · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 451 followers
View post →
R1M 900 VA
@MahinFatavit · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 5,965 followers
View post →
RDK. Ratu Dewi Kirana
@ratudewikirana · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 24, 2020 · 38 shares · 417 followers
View post →
diBui
@msabir2 · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 320 followers
View post →
phii
@apeekapo · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 103 followers
View post →
hansbacara
@hansbacara · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 353 followers
View post →
#TT Dewi Darmawati
@dewi_darmawati · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 20,290 followers
View post →
evie
@off__vie · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 604 followers
View post →
Nia
@nia_vet · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 335 followers
View post →
Misbah مصباح ig :NalarKuantitatif
@bangmis · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 1,227 followers
View post →
DRHydee v2.0
@DRHydee2 · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 282 followers
View post →
ur_jeonji
@ur_jeonji · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 277 followers
View post →
ditra’s mom
@prabuditra · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 2,852 followers
View post →
Ar
@masteriwagra · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 284 followers
View post →
울란
@waterwul · X
RT @KangSantabrata: INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb ka…
Mar 23, 2020 · 38 shares · 709 followers
View post →
Kang Santabrata
@KangSantabrata · X
INDONESIA MUSTI LEBIH CEPAT LEBIH AGGRESIF (5 of 7) Tanpa perubahan battle plan Pemerintah, tanggal 21 April, 100rb kasus berarti 58rb perlu dirawat (58%), 5rb perlu ICU (5%) dan 3400 diperkirakan meninggal (3,4% CFR WHO). Siap? Ref: https://t.co/cc7X4jmEoX #Covid19 https://t.co/fgoNZz37Lb
Mar 23, 2020 · 33 likes · 38 shares · 988 followers
View post →
MeaghieWalkerWilliams
@MeaghieC · X
RT @RanuDhillon: @AbraarKaran @laxswamy @srijeeva @kj_seung @DrTomFrieden @Craig_A_Spencer "No..abnormality..in 157 of 877 patients (17.9%)…
Mar 23, 2020 · 1 share · 1,702 followers
View post →
Ranu Dhillon
@RanuDhillon · X
@AbraarKaran @laxswamy @srijeeva @kj_seung @DrTomFrieden @Craig_A_Spencer "No..abnormality..in 157 of 877 patients (17.9%) w/nonsevere dz & in 5 of 173 patients (2.9%) w/severe dz" Need definitive data as variable results in studies. Regardless, may still be adequately sensitive combined w/other tool (ie, rapid ag/ab test). https://t.co/9ZxEeNDN0U
Mar 23, 2020 · 1 like · 1 share · 8,976 followers
View post →
Ming
@MingsChirps · X
@PhillipCompeau "The median duration of hospitalization was 12.0 days (mean, 12.8)" . Some data from this paper: https://t.co/G5wd4NrLW3
Mar 23, 2020 · 188 followers
View post →
Jukka Kelovuori
@jkelovuori · X
@dansus @GregTHR @aafp One study here. https://t.co/FsV1chxb9v https://t.co/u4Qw17OfRF
Mar 22, 2020 · 5 likes · 1 share · 5,880 followers
View post →
Jokerified Tyrion
@SocialistTyrion · X
Amigos y amigas de México. Ayer grabé un Podcast con mi amigo el Dr. Mario Pérez donde hablamos acerca del #Coronavirus y especificamente de la situación en MX. El propósito es informar a la gente en medio de tanta desinformación que existe sobre esto: https://t.co/pYn4cGikwv
Mar 22, 2020 · 846 followers
View post →
Marcel ML
@sankari83 · X
@c_drosten @NDRinfo Gibt es schon Zahlen aus Europa (D, I, E oder F) zu den schweren Verläufen (inkl. Beatmung) bei Jüngeren? Ich finde die chinesischen Daten spiegeln sich zu wenig in den Medien wieder, falls belastbar. https://t.co/DRxUhlezUT https://t.co/YgnypOrsrA
Mar 22, 2020 · 237 followers
View post →
Dr Jennie C
@DrJennieC · X
RT @jimgthornton: Some Covid19 links. Primary data only. Lancet 41 cases https://t.co/sxRJhbbKFP, JAMA 138 https://t.co/ZaN1P5d0ln, & NEJM…
Mar 22, 2020 · 29 shares · 160 followers
View post →
SKShadab Khan
@skhanshadab87 · X
@PalmerLyle @DrLukeOR "No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease." From 1099 Chinese patients who were diagnosed COVID +ve and admitted. https://t.co/QRCRb3djWx
Mar 21, 2020 · 1 like · 211 followers
View post →
JMjohn middleton
@doctorblooz · X
RT @jimgthornton: Some Covid19 links. Primary data only. Lancet 41 cases https://t.co/sxRJhbbKFP, JAMA 138 https://t.co/ZaN1P5d0ln, & NEJM…
Mar 21, 2020 · 29 shares · 2,216 followers
View post →
nedjem
@dialingnumber81 · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 19, 2020 · 10 shares · 12 followers
View post →
Victor Chang Cardiac Research Institute
@victorchang.edu.au · Bluesky
#BobisReading this article from @nejm- 'Clinical Characteristics of Coronavirus Disease 2019 in China' which examines the characteristics of patients from the first two months of outbreak nejm.org/doi/pdf/10.105…
Mar 19, 2020
View post →
Victor Chang Cardiac Research Institute
@victorchang.edu.au · Bluesky
#BobisReading this article from @nejm- 'Clinical Characteristics of Coronavirus Disease 2019 in China' which examines the characteristics of patients from the first two months of outbreak nejm.org/doi/pdf/10.105…
Mar 19, 2020
View post →
Joshua Skootsky
@Joshua_Skootsky · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 18, 2020 · 10 shares · 599 followers
View post →
Mars0986
@Mars0986 · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 18, 2020 · 10 shares · 135 followers
View post →
Si Jones
@conky30 · X
https://t.co/6hJR208zQu
Mar 17, 2020 · 1 like · 1,277 followers
View post →
One More Go.
@puffdabong · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/2GgcC4wuZT via @YouTube
Mar 17, 2020 · 57 followers
View post →
Tomoyo
@nziu_z · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 17, 2020 · 10 shares · 157 followers
View post →
リアム
@konsolitus · X
And, to really drive down the point, watch & subscribe to @chubbyemu https://t.co/S3jL60jbNg
Mar 17, 2020 · 501 followers
View post →
Deborah A. McCallum
@mccallumdmcc · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/L3MZYUs82s via @YouTube
Mar 16, 2020 · 82 followers
View post →
Tony Unplugged
@TonyUnplugged · X
@StevePieczenik @Non_MSM_News @LouDobbs @realDonaldTrump @DonaldJTrumpJr Understanding COVID-19 From Cases Described By Doctors In China https://t.co/wQ8vttAYdv
Mar 16, 2020 · 2,961 followers
View post →
Adesh
@AdeshAtole · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/ieJAP7z4Lf via @YouTube
Mar 16, 2020 · 379 followers
View post →
DA
@DanielAndrewMe · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/StlcSvYuxt
Mar 16, 2020 · 319 followers
View post →
RAVENHONEY
@RAVENHONEYGAMER · X
RT @alwaysJiji: https://t.co/yV7c64NTVC
Mar 16, 2020 · 310 followers
View post →
AlwaysJiji
@alwaysJiji · X
https://t.co/yV7c64NTVC
Mar 16, 2020 · 1 like · 268 followers
View post →
Sol ✨
@Sol_HybridDeer · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 10 shares · 4,006 followers
View post →
Lisa Zimmerman
@ZimmBioGal · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 10 shares · 133 followers
View post →
sam !!
@shadviio · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 10 shares · 217 followers
View post →
GrayTramp
@GrayTramp · X
RT @chubbyemu: I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 10 shares · 127 followers
View post →
Chubbyemu
@chubbyemu · X
I am making video version of each episode for the time being This is the first episode
Mar 16, 2020 · 78 likes · 10 shares · 104,574 followers
View post →
Scott Dark
@ScottxDark · X
@malenatudi https://t.co/NW4GiqgaFr
Mar 16, 2020 · 35 followers
View post →
Warsy Gahiefuh
@Warsywarsy · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/6pgIcwSi93 via @YouTube
Mar 16, 2020 · 2,197 followers
View post →
Bat Eats Moth
@BatEatsMoth · X
Understanding COVID-19 From Cases Described By Doctors In China https://t.co/PRB1sThiD0 via @YouTube
Mar 15, 2020 · 12,575 followers
View post →
Abhimanyu Mahajan
@amahajanmd.bsky.social · Bluesky
https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
Mar 7, 2020
View post →
kotonoha
@komakusanohana · X
中国の新型コロナウイルス感染症患者1099人のデータ。来院時37.5℃未満が半数以上。入院中も超えなかった人が9.9％もいる。発熱したら連絡してね、の根底が揺らぐのです。NEJMってジャーナル名まで挙げてヒトーヒト感染について言うなら、つついて欲しかったな。 https://t.co/Uenj68P0Eo
Mar 2, 2020 · 422 followers
View post →
No mentions from this source yet.